Quality of life, symptoms and patients expectations in one year pirfenidone treatment.

Version 2 2022-05-21, 13:57

Version 1 2022-02-03, 23:20

dataset

posted on 2022-05-21, 13:57 authored by Dariusz Jastrzebski, Sabina Kostorz-NosalSabina Kostorz-Nosal, Warzecha Joanna, Sebastian Majewski, Piotrowski, Wojciech, Dariusz Ziora

The study aimed to assess quality of life, expectations and disease symptoms in patients with idiopathic interstitial pneumoania at baseline and after one year of pirfenidone treatment.

Funding

PCN-1-194/N/0/K

2016/23/N/NZ7/02002

History

Usage metrics

Keywords

anti-fibrotic therapies quality of life dyspnoea cough fatigue patients’ expectations idiopathic pulmonary fibrosis pirfenidone Medicine

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM